Literature DB >> 10451446

Mammographic densities and risk of breast cancer among subjects with a family history of this disease.

N F Boyd1, G A Lockwood, L J Martin, J A Knight, R A Jong, E Fishell, J W Byng, M J Yaffe, D L Tritchler.   

Abstract

BACKGROUND: A family history of breast cancer is known to increase risk of the disease, but other genetic and environmental factors that modify this risk are likely to exist. One of these factors is mammographic density, and we have sought evidence that it is associated with increased risk of breast cancer among women with a family history of breast cancer.
METHODS: We used data from a nested case-control study based on the Canadian National Breast Screening Study (NBSS). From 354 case patients with incident breast cancer detected at least 12 months after entry into the NBSS and 354 matched control subjects, we analyzed subjects who were identified as having a family history of breast cancer according to one of three, nonmutually exclusive, criteria. We compared the mammographic densities of case patients and control subjects by radiologic and computer-assisted methods of measurement.
RESULTS: After adjustment for other risk factors for breast cancer, the relative risks (RRs) between the most and least extensive categories of breast density were as follows: For at least one first-degree relative with breast cancer, RR = 11.14 (95% confidence interval [CI] = 1.54-80.39); for at least two affected first- or second-degree relatives, RR = 2.57 (95% CI = 0.23-28.22); for at least one first- or second-degree relative with breast cancer, RR = 5.43 (95% CI = 1.85-15.88).
CONCLUSIONS: These results suggest that mammographic density may be strongly associated with risk of breast cancer among women with a family history of the disease. Because mammographic densities can be modified by dietary and hormonal interventions, the results suggest potential approaches to the prevention of breast cancer in women with a family history of breast cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10451446     DOI: 10.1093/jnci/91.16.1404

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women.

Authors:  Mary Beth Terry; Diana S M Buist; Amy Trentham-Dietz; Tamarra M James-Todd; Yuyan Liao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

2.  Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer.

Authors:  Lusine Yaghjyan; Graham A Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2012-03-23       Impact factor: 2.506

3.  Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.

Authors:  Gretchen L Gierach; Jennifer T Loud; Catherine K Chow; Sheila A Prindiville; Jennifer Eng-Wong; Peter W Soballe; Claudia Giambartolomei; Phuong L Mai; Claudia E Galbo; Kathryn Nichols; Kathleen A Calzone; Celine Vachon; Mitchell H Gail; Mark H Greene
Journal:  Breast Cancer Res Treat       Date:  2010-02-04       Impact factor: 4.872

4.  Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis--analysis of 102,577 diagnostic procedures.

Authors:  Fritz K W Schaefer; A Waldmann; A Katalinic; C Wefelnberg; M Heller; W Jonat; I Schreer
Journal:  Eur Radiol       Date:  2009-11-05       Impact factor: 5.315

5.  Mammographic breast density response to aromatase inhibition.

Authors:  Celine M Vachon; Vera J Suman; Kathleen R Brandt; Matthew L Kosel; Aman U Buzdar; Janet E Olson; Fang-Fang Wu; Lynn M Flickinger; Giske Ursin; Catherine R Elliott; Lois Shepherd; Richard M Weinshilboum; Paul E Goss; James N Ingle
Journal:  Clin Cancer Res       Date:  2013-03-06       Impact factor: 12.531

6.  Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.

Authors:  Wei Tse Yang; Michael T Lewis; Kenneth Hess; Helen Wong; Anna Tsimelzon; Nese Karadag; Michelina Cairo; Caimaio Wei; Funda Meric-Bernstam; Powel Brown; Banu Arun; Gabriel N Hortobagyi; Aysegul Sahin; Jenny C Chang
Journal:  Breast Cancer Res Treat       Date:  2009-02-25       Impact factor: 4.872

7.  Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women.

Authors:  Karthik Ghosh; Kathleen R Brandt; Thomas A Sellers; Carol Reynolds; Christopher G Scott; Shaun D Maloney; Michael J Carston; V Shane Pankratz; Celine M Vachon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

8.  Comparison of percent density from raw and processed full-field digital mammography data.

Authors:  Celine M Vachon; Erin Ee Fowler; Gail Tiffenberg; Christopher G Scott; V Shane Pankratz; Thomas A Sellers; John J Heine
Journal:  Breast Cancer Res       Date:  2013-01-04       Impact factor: 6.466

Review 9.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

10.  Dietary intake and breast density in high-risk women: a cross-sectional study.

Authors:  Marilyn Tseng; Celia Byrne; Kathryn A Evers; Mary B Daly
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.